1373766-52-9 Usage
Uses
Used in Pharmaceutical Industry:
(5-(3-(methoxymethyl)phenyl)-2-methyloxazole-4-yl)methanol is used as a potential active pharmaceutical ingredient due to its oxazole derivative nature, which is known for exhibiting antibacterial, antifungal, and anticancer properties. Its unique structure may allow it to interact with biological targets, making it a candidate for the development of new drugs.
Used in Organic Synthesis:
(5-(3-(methoxymethyl)phenyl)-2-methyloxazole-4-yl)methanol is used as a precursor in the synthesis of other organic molecules, particularly because of the presence of the methanol group. (5-(3-(methoxymethyl)phenyl)-2-methyloxazole-4-yl)methanol can be a starting material for creating a variety of complex organic compounds for different applications, including but not limited to pharmaceuticals, agrochemicals, and specialty chemicals.
Used in Chemical Research:
(5-(3-(methoxymethyl)phenyl)-2-methyloxazole-4-yl)methanol is used as a research compound for studying the properties and reactivity of oxazole and phenyl derivatives. Its unique structure can provide insights into the development of new synthetic methods and understanding the relationship between chemical structure and biological activity.
Check Digit Verification of cas no
The CAS Registry Mumber 1373766-52-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,3,7,6 and 6 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1373766-52:
(9*1)+(8*3)+(7*7)+(6*3)+(5*7)+(4*6)+(3*6)+(2*5)+(1*2)=189
189 % 10 = 9
So 1373766-52-9 is a valid CAS Registry Number.
1373766-52-9Relevant academic research and scientific papers
DIAZA-SPIRO[5.5]UNDECANES USEFUL AS OREXIN RECEPTOR ANTAGONISTS
-
, (2012/05/19)
The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
Diaza-spiro[5.5]undecanes
-
, (2012/05/04)
The invention relates to compound of the formula I in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
DI/TRI-AZA-SPIRO-C9-C11ALKANES
-
, (2012/08/08)
The invention relates to compounds of the formula I A-D-C(R1)2-B (I), in which A and B are aromatic ring systems and wherein D is selected from the groups D1 to D5 and the other substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
Di/tri-aza-spiro-C9-C11alkanes
-
, (2012/07/13)
The invention relates to compounds of the formula I [in-line-formulae]A-D-C(R1)2—B??(I),[/in-line-formulae] in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
